Kerusso Capital Management
ABBV icon

Kerusso Capital Management’s AbbVie ABBV Stock Holding History

Kerusso Capital Management’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$6.48M Buy
24,786
+2,275
+10% +$583K 2.12% 14
2026
Q2 		$5.66M Buy
22,511
+4,279
+23% +$921K 2.06% 14
2026
Q1 		$3.97M Buy
18,232
+8,787
+93% +$1.95M 1.99% 18
2025
Q4 		$2.16M Buy
9,445
+2,266
+32% +$516K 1% 52
2025
Q3 		$1.66M Sell
7,179
-390
-5% -$79.4K 1.02% 48
2025
Q2 		$1.4M Sell
7,569
-8,425
-53% -$1.57M 0.87% 52
2025
Q1 		$3.35M Buy
15,994
+9,322
+140% +$1.81M 2.13% 18
2024
Q4 		$1.19M Buy
6,672
+14
+0.2% +$2.57K 0.76% 56
2024
Q3 		$1.31M Buy
6,658
+406
+6% +$75.8K 0.84% 57
2024
Q2 		$1.07M Buy
+6,252
New +$1.04M 0.78% 54

Other funds holding ABBV

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $608B AUM 32.77% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $765B AUM 28.39% 1-Year Est. Return
Amundi
Amundi Paris, France $496B AUM 35.36% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $362B AUM 34.89% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $348B AUM 26.9% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $420B AUM 34.97% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $551B AUM 33.95% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $111B AUM 30.48% 1-Year Est. Return

Kerusso Capital Management's ABBV Position: Q3 2026 in Review

Kerusso Capital Management increased its AbbVie (ABBV) stake by 10% in Q3 2026, buying an estimated $583K and bringing the position to 24,786 shares worth $6.48M. The position accounts for 2.12% of the portfolio, ranked #14.

Kerusso Capital Management first reported a position in ABBV in Q2 2024 and has held it in 10 quarters since. 3,064 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Kerusso Capital Management held 24,786 shares of AbbVie worth $6.48M as of Q3 2026.
  • Kerusso Capital Management bought 2,275 AbbVie shares in Q3 2026, an estimated $583K.
  • AbbVie made up 2.12% of Kerusso Capital Management's portfolio in Q3 2026, its #14 holding.
  • Kerusso Capital Management first reported a position in AbbVie in Q2 2024 and has held it in 10 quarters since.
  • 3,064 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Kerusso Capital Management's 13F filing for Q3 2026, filed 27 Oct 2026.